Back to Journals » Vascular Health and Risk Management » Volume 10

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]

Authors Hamano K, Nakadaira I, Suzuki J, Gonai M

Received 9 October 2014

Accepted for publication 9 October 2014

Published 13 November 2014 Volume 2014:10 Pages 649—650

DOI https://doi.org/10.2147/VHRM.S75591


Hamano K, Nakadaira I, Suzuki J, Gonai M. Vasc Health Risk Manag. 2014;10:585–589.

On page 587, please note that Table 1 was incorrect. The correct table is provided.
 
Read the original paper

Table 1 Characteristics of subjects with and without diabetic complications
Notes: Data are mean ± SD. *Presence of any of diabetic complications (DMR, nephropathy, DSN, CVD, and PAD). P-values in bold were demonstrated to have adequate effect size.
Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; NT-proBNP, N-terminal fragment of probrain natriuretic peptide; IMTL, intima media thickness of left carotid; IMTR, intima media thickness of right carotid; PWV, pulse wave velocity; ABI, ankle brachial index; LVH, left ventricular hypertrophy; eGFR, estimated glomerular filtration rate; R, right; L, left; SD, standard deviation; CVD, cardiovascular disease; PAD, peripheral artery disease; DMR, diabetes mellitus retinopathy; DSN, distal sensory neuropathy.


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]